Skip to content

Enzygnost Anti-CMV/IGM

by Behring Diagnostics, Inc. 510(k)

Active United States

510(k) K913693

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK913693 Date27 Feb 1992ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 5 Oct 2026.

Specification

510(k)

Full name
Enzygnost(R) Anti-Cmv/Igm
510(k) Number
FDA Product Code
LFZ
Device Class
Class II
Regulation
21 CFR Part 866.3175
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Enzygnost Anti-CMV/IGM is an enzyme-linked immunoabsorbent assay (ELISA) designed for the qualitative detection of IgM antibodies to cytomegalovirus (CMV). This diagnostic test aids in identifying acute or primary CMV infection by detecting specific IgM class antibodies in human serum or plasma samples, supporting clinical assessment in microbiology settings.

This device is supplied as a single-use in vitro diagnostic reagent kit and requires laboratory processing. It is intended for use in clinical microbiology laboratories and has received FDA 510(k) clearance under the classification of microbiology devices (product code LFZ, regulation number 866.3175). The assay is not intended for MRI use and must be stored according to manufacturer instructions to maintain integrity until use.

Other devices from Behring Diagnostics, Inc.

See all devices from Behring Diagnostics, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Enzygnost Anti-CMV/IGM used for?

    This device is an enzyme-linked immunoabsorbent assay (ELISA) designed to qualitatively detect IgM antibodies specific to cytomegalovirus (CMV). It helps clinicians identify acute or primary CMV infections by analyzing human serum or plasma samples, supporting diagnostic assessments in microbiology settings.

  • How is the Enzygnost Anti-CMV/IGM supplied and intended for use?

    The kit is supplied as a single-use in vitro diagnostic reagent, requiring laboratory processing. It is intended exclusively for use in clinical microbiology laboratories to assist in diagnosing CMV infections through IgM antibody detection.

  • Is the Enzygnost Anti-CMV/IGM sterile and single-use?

    Yes, the device is supplied as a single-use reagent kit. While the exact sterility claims are not detailed, its design as a diagnostic reagent implies it is intended for one-time use per sample to prevent cross-contamination and ensure accurate results.

  • What storage instructions apply to the Enzygnost Anti-CMV/IGM?

    The kit must be stored according to the manufacturer’s instructions to preserve its integrity until use. Proper storage conditions are critical to maintaining the assay’s performance, as exposure to improper temperatures or light could compromise the reagents.

  • Can this device be used for MRI or other imaging purposes?

    No, the Enzygnost Anti-CMV/IGM is explicitly not intended for MRI use. It is solely designed for laboratory-based diagnostic testing of serum or plasma samples to detect CMV IgM antibodies.